Analyze Diet
Equine veterinary journal2023; 55(5); 884-890; doi: 10.1111/evj.13907

Vitamin E depletion is associated with subclinical axonal degeneration in juvenile horses.

Abstract: Phosphorylated neurofilament heavy, a marker of neuroaxonal damage, is increased in horses with equine neuroaxonal dystrophy. However, the temporal dynamics of this biomarker during the post-natal risk period are not understood. Objective: To measure serum and cerebrospinal fluid phosphorylated neurofilament heavy concentrations in juvenile foals across the post-natal window of susceptibility for equine neuroaxonal dystrophy. Methods: Case-control in vivo experimental study. Methods: Concentrations of phosphorylated neurofilament heavy were measured using frozen serum and cerebrospinal fluid collected from 13 foals raised in a vitamin E deficient environment from 1 to 6 months of age. Four of these foals were produced by equine neuroaxonal dystrophy-affected dams, developed clinical signs consistent with equine neuroaxonal dystrophy and had a diagnosis confirmed by histopathology. The remaining nine foals, produced by healthy mares, were vitamin E depleted and remained clinically healthy. An additional cohort of foals, produced by healthy mares, were supplemented with vitamin E (α-tocopherol; α-TOH) from birth and sampled similarly. Results: Serum α-TOH concentrations were significantly higher in vitamin E supplemented healthy foals. Serum phosphorylated neurofilament heavy concentrations did not differ significantly between groups at any time point. Cerebrospinal fluid phosphorylated neurofilament heavy concentrations increased with age in healthy vitamin E depleted foals (p < 0.001); an effect that was not observed in healthy vitamin E supplemented foals. Conclusions: A genetically susceptible cohort supplemented with vitamin E was not available for comparison. Conclusions: We demonstrate that vitamin E depletion may elevate cerebrospinal fluid phosphorylated neurofilament heavy in otherwise healthy juvenile foals by 6 months of age. We highlight an important cofactor to consider when interpreting cerebrospinal fluid phosphorylated neurofilament heavy concentrations in juvenile horses.
Publication Date: 2023-01-04 PubMed ID: 36516303PubMed Central: PMC10264549DOI: 10.1111/evj.13907Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study examines how vitamin E deficiency in young horses contributes to neurodegeneration, using phosphorylated neurofilament heavy as an indicator.

Study Objective

The main aim of the study was to understand the concentrations of phosphorylated neurofilament heavy in the serum and cerebrospinal fluid of young foals during the post-natal susceptibility phase for equine neuroaxonal dystrophy.

Study Methods

The researchers carried out a case-control experimental study in a live setting with 13 foals that were brought up in an environment deficient in vitamin E for six months. Out of these foals:

  • Four were foals from mothers affected by equine neuroaxonal dystrophy, developed clinical signs of the disease, and were diagnosed through histopathology.
  • Nine foals were born to healthy mares, had vitamin E deficiency but remained clinically healthy.

Additionally, a separate group of foals that were born to healthy mares were supplemented with vitamin E from birth for comparison.

Study Results

The results revealed that:

  • Foals supplemented with vitamin E (α-tocopherol; α-TOH) had significantly higher serum α-TOH concentrations than those with a deficiency.
  • No significant differences were observed in the serum phosphorylated neurofilament heavy concentrations between the groups at any time point.
  • Cerebrospinal fluid phosphorylated neurofilament heavy concentrations increased with age in healthy foals with vitamin E deficiency, an effect not apparent in foals supplemented with vitamin E.
  • Susceptible foals supplemented with vitamin E were not available for comparison in the study.

Study Conclusion

The study concluded that vitamin E deficiency might raise the levels of phosphorylated neurofilament heavy in the cerebrospinal fluid of otherwise healthy juvenile foals by six months of age. The results underscore the importance of considering this cofactor when interpreting cerebrospinal fluid phosphorylated neurofilament heavy concentrations in juvenile horses.

Cite This Article

APA
Donnelly CG, Finno CJ. (2023). Vitamin E depletion is associated with subclinical axonal degeneration in juvenile horses. Equine Vet J, 55(5), 884-890. https://doi.org/10.1111/evj.13907

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 55
Issue: 5
Pages: 884-890

Researcher Affiliations

Donnelly, Callum G
  • Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, California, USA.
Finno, Carrie J
  • Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, California, USA.

MeSH Terms

  • Animals
  • Horses
  • Female
  • Vitamin E
  • alpha-Tocopherol / cerebrospinal fluid
  • Dietary Supplements
  • Neuroaxonal Dystrophies / veterinary
  • Horse Diseases
  • Vitamins

Grant Funding

  • K01 OD015134 / NIH HHS
  • L40 TR001136 / NCATS NIH HHS
  • K01OD015134 / NIH HHS
  • L40 TR001136 / NIH HHS

Conflict of Interest Statement

Authors’ declarations of interests. No competing interests have been declared.

References

This article includes 30 references
  1. Finno CJ, Valberg SJ, Shivers J, D'Almeida E, Armién AG. Evidence of the Primary Afferent Tracts Undergoing Neurodegeneration in Horses With Equine Degenerative Myeloencephalopathy Based on Calretinin Immunohistochemical Localization.. Vet Pathol 2016 Jan;53(1):77-86.
    doi: 10.1177/0300985815598787pmc: PMC4831571pubmed: 26253880google scholar: lookup
  2. Burns EN, Finno CJ. Equine degenerative myeloencephalopathy: prevalence, impact, and management.. Vet Med (Auckl) 2018;9:63-67.
    doi: 10.2147/VMRR.S148542pmc: PMC6135079pubmed: 30234005google scholar: lookup
  3. Mayhew IG, deLahunta A, Whitlock RH, Geary JC. Equine degenerative myeloencephalopathy.. J Am Vet Med Assoc 1977 Jan 15;170(2):195-201.
    pubmed: 833044
  4. Beech J. Neuroaxonal dystrophy of the accessory cuneate nucleus in horses.. Vet Pathol 1984 Jul;21(4):384-93.
    doi: 10.1177/030098588402100404pubmed: 6464300google scholar: lookup
  5. Finno CJ, Peterson J, Kang M, Park S, Bordbari MH, Durbin-Johnson B, Settles M, Perez-Flores MC, Lee JH, Yamoah EN. Single-Cell RNA-seq Reveals Profound Alterations in Mechanosensitive Dorsal Root Ganglion Neurons with Vitamin E Deficiency.. iScience 2019 Nov 22;21:720-735.
    doi: 10.1016/j.isci.2019.10.064pmc: PMC6864320pubmed: 31733517google scholar: lookup
  6. Finno CJ, Bordbari MH, Gianino G, Ming-Whitfield B, Burns E, Merkel J, Britton M, Durbin-Johnson B, Sloma EA, McMackin M, Cortopassi G, Rivas V, Barro M, Tran CK, Gennity I, Habib H, Xu L, Puschner B, Miller AD. An innate immune response and altered nuclear receptor activation defines the spinal cord transcriptome during alpha-tocopherol deficiency in Ttpa-null mice.. Free Radic Biol Med 2018 May 20;120:289-302.
  7. Finno CJ, Bordbari MH, Valberg SJ, Lee D, Herron J, Hines K, Monsour T, Scott E, Bannasch DL, Mickelson J, Xu L. Transcriptome profiling of equine vitamin E deficient neuroaxonal dystrophy identifies upregulation of liver X receptor target genes.. Free Radic Biol Med 2016 Dec;101:261-271.
  8. Kohlschütter A, Finckh B, Nickel M, Bley A, Hübner C. First Recognized Patient with Genetic Vitamin E Deficiency Stable after 36 Years of Controlled Supplement Therapy.. Neurodegener Dis 2020;20(1):35-38.
    doi: 10.1159/000508080pubmed: 32623435google scholar: lookup
  9. Edwards LA, Donnelly CG, Reed SM, Valberg S, Chigerwe M, Johnson AL, Finno CJ. Serum and cerebrospinal fluid phosphorylated neurofilament heavy protein concentrations in equine neurodegenerative diseases.. Equine Vet J 2022 Mar;54(2):290-298.
    doi: 10.1111/evj.13452pubmed: 33969539google scholar: lookup
  10. Hales EN, Habib H, Favro G, Katzman S, Sakai RR, Marquardt S, Bordbari MH, Ming-Whitfield B, Peterson J, Dahlgren AR, Rivas V, Ramirez CA, Peng S, Donnelly CG, Dizmang BS, Kallenberg A, Grahn R, Miller AD, Woolard K, Moeller B, Puschner B, Finno CJ. Increased α-tocopherol metabolism in horses with equine neuroaxonal dystrophy.. J Vet Intern Med 2021 Sep;35(5):2473-2485.
    doi: 10.1111/jvim.16233pmc: PMC8478026pubmed: 34331715google scholar: lookup
  11. Motobayashi M, Fukuyama T, Okuno-Yuguchi J, Tsukahara K, Nagaharu S, Hagimoto R, Kinoshita T, Nakazawa Y, Inaba Y. Subclinical Neuroaxonal Damage in Patients With Clinically Mild Encephalitis/Encephalopathy With a Reversible Splenial Lesion.. Pediatr Neurol 2017 Sep;74:e3-e4.
  12. Matsushige T, Ichiyama T, Kajimoto M, Okuda M, Fukunaga S, Furukawa S. Serial cerebrospinal fluid neurofilament concentrations in bacterial meningitis.. J Neurol Sci 2009 May 15;280(1-2):59-61.
    doi: 10.1016/j.jns.2009.01.021pubmed: 19237165google scholar: lookup
  13. Douglas-Escobar M, Yang C, Bennett J, Shuster J, Theriaque D, Leibovici A, Kays D, Zheng T, Rossignol C, Shaw G, Weiss MD. A pilot study of novel biomarkers in neonates with hypoxic-ischemic encephalopathy.. Pediatr Res 2010 Dec;68(6):531-6.
  14. Lee T, Chikkabyrappa SM, Reformina D, Mastrippolito A, Chakravarti SB, Mosca RS, Shaw G, Malhotra SP. Ubiquitin C-Terminal Hydrolase 1 and Phosphorylated Axonal Neurofilament Heavy Chain in Infants Undergoing Cardiac Surgery: Preliminary Assessment as Potential Biomarkers of Brain Injury.. World J Pediatr Congenit Heart Surg 2018 Jul;9(4):412-418.
    doi: 10.1177/2150135118762390pubmed: 29945509google scholar: lookup
  15. McPhillips L, Kholwadwala D, Sison CP, Gruber D, Ojamaa K. A Novel Brain Injury Biomarker Correlates with Cyanosis in Infants with Congenital Heart Disease.. Pediatr Cardiol 2019 Mar;40(3):546-553.
    doi: 10.1007/s00246-018-2023-4pubmed: 30430186google scholar: lookup
  16. Goeral K, Hauck A, Atkinson A, Wagner MB, Pimpel B, Fuiko R, Klebermass-Schrehof K, Leppert D, Kuhle J, Berger A, Olischar M, Wellmann S. Early life serum neurofilament dynamics predict neurodevelopmental outcome of preterm infants.. J Neurol 2021 Jul;268(7):2570-2577.
    doi: 10.1007/s00415-021-10429-5pmc: PMC8217001pubmed: 33566157google scholar: lookup
  17. Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, Barro C, Kappos L, Comabella M, Fazekas F, Petzold A, Blennow K, Zetterberg H, Kuhle J. Neurofilaments as biomarkers in neurological disorders.. Nat Rev Neurol 2018 Oct;14(10):577-589.
    doi: 10.1038/s41582-018-0058-zpubmed: 30171200google scholar: lookup
  18. Traber MG. Vitamin E: necessary nutrient for neural development and cognitive function.. Proc Nutr Soc 2021 Aug;80(3):319-326.
    doi: 10.1017/S0029665121000914pmc: PMC8842820pubmed: 33896432google scholar: lookup
  19. Péter S, Friedel A, Roos FF, Wyss A, Eggersdorfer M, Hoffmann K, Weber P. A Systematic Review of Global Alpha-Tocopherol Status as Assessed by Nutritional Intake Levels and Blood Serum Concentrations.. Int J Vitam Nutr Res 2015 Dec;85(5-6):261-281.
    doi: 10.1024/0300-9831/a000281pubmed: 27414419google scholar: lookup
  20. Finno CJ, Estell KE, Katzman S, Winfield L, Rendahl A, Textor J, Bannasch DL, Puschner B. Blood and Cerebrospinal Fluid α-Tocopherol and Selenium Concentrations in Neonatal Foals with Neuroaxonal Dystrophy.. J Vet Intern Med 2015 Nov-Dec;29(6):1667-75.
    doi: 10.1111/jvim.13618pmc: PMC4831564pubmed: 26391904google scholar: lookup
  21. National Research Council (US) Nutrient requirements of horses. Washington, D.C: National Academies Press. 2007.
  22. Aleman M, Finno CJ, Higgins RJ, Puschner B, Gericota B, Gohil K, LeCouteur RA, Madigan JE. Evaluation of epidemiological, clinical, and pathological features of neuroaxonal dystrophy in Quarter Horses.. J Am Vet Med Assoc 2011 Sep 15;239(6):823-33.
    doi: 10.2460/javma.239.6.823pubmed: 21916766google scholar: lookup
  23. Lee VM, Otvos L Jr, Carden MJ, Hollosi M, Dietzschold B, Lazzarini RA. Identification of the major multiphosphorylation site in mammalian neurofilaments.. Proc Natl Acad Sci U S A 1988 Mar;85(6):1998-2002.
    doi: 10.1073/pnas.85.6.1998pmc: PMC279909pubmed: 2450354google scholar: lookup
  24. Ringger NC, Giguère S, Morresey PR, Yang C, Shaw G. Biomarkers of brain injury in foals with hypoxic-ischemic encephalopathy.. J Vet Intern Med 2011 Jan-Feb;25(1):132-7.
  25. Morales Gómez AM, Zhu S, Palmer S, Olsen E, Ness SL, Divers TJ, Bischoff K, Mohammed HO. Analysis of neurofilament concentration in healthy adult horses and utility in the diagnosis of equine protozoal myeloencephalitis and equine motor neuron disease.. Res Vet Sci 2019 Aug;125:1-6.
    doi: 10.1016/j.rvsc.2019.04.018pubmed: 31103855google scholar: lookup
  26. Intan-Shameha AR, Divers TJ, Morrow JK, Graves A, Olsen E, Johnson AL, Mohammed HO. Phosphorylated neurofilament H (pNF-H) as a potential diagnostic marker for neurological disorders in horses.. Res Vet Sci 2017 Oct;114:401-405.
    doi: 10.1016/j.rvsc.2017.07.020pubmed: 28750210google scholar: lookup
  27. Wobbrock JO, Findlater L, Gergle D, Higgins JJ. The aligned rank transform for nonparametric factorial analyses using only anova procedures. Proceedings of the SIGCHI conference on human factors in computing systems 2011;pp. 143–146.
  28. Altmann P, Leutmezer F, Zach H, Wurm R, Stattmann M, Ponleitner M, Petzold A, Zetterberg H, Berger T, Rommer P, Bsteh G. Serum neurofilament light chain withstands delayed freezing and repeated thawing.. Sci Rep 2020 Nov 17;10(1):19982.
    doi: 10.1038/s41598-020-77098-8pmc: PMC7672085pubmed: 33203974google scholar: lookup
  29. Barton MH, Morris DD, Crowe N, Collatos C, Prasse KW. Hemostatic indices in healthy foals from birth to one month of age.. J Vet Diagn Invest 1995 Jul;7(3):380-5.
    doi: 10.1177/104063879500700314pubmed: 7578455google scholar: lookup
  30. Tate J, Ward G. Interferences in immunoassay.. Clin Biochem Rev 2004 May;25(2):105-20.
    pmc: PMC1904417pubmed: 18458713

Citations

This article has been cited 2 times.
  1. Chen M, Ghelfi M, Poon JF, Jeon N, Boccalon N, Rubsamen M, Valentino S, Mehta V, Stamper M, Tariq H, Zunica E, Ulatowski L, Chung S, Fritz C, Cameron M, Cameron C, Pratt DA, Atkinson J, Finno CJ, Manor D. Antioxidant-independent activities of alpha-tocopherol. J Biol Chem 2025 Apr;301(4):108327.
    doi: 10.1016/j.jbc.2025.108327pubmed: 39978678google scholar: lookup
  2. Palmisano M, Kulp J, Bender S, Stefanovski D, Robinson M, Johnson A. Measurement of 8-hydroxy-2'-deoxyguanosine in serum and cerebrospinal fluid of horses with neuroaxonal degeneration and other causes of proprioceptive ataxia. J Vet Intern Med 2024 Mar-Apr;38(2):1207-1213.
    doi: 10.1111/jvim.16988pubmed: 38205913google scholar: lookup